Addictive behaviors
September 1, 2022
Kevin H Yang, Benjamin H Han, Joseph J Palamar
30 citations
LSD use was linked with a higher likelihood of major depressive episodes and suicidal thinking, while salvia divinorum use was associated with increased suicidal thinking and DMT/AMT/Foxy use with suicidal planning. In contrast, ecstasy (MDMA) use was linked with a lower likelihood of serious psychological distress, major depressive episodes, and suicidal thinking. These findings from a large US national survey indicate that different hallucinogens have distinct associations with depression and suicidality, highlighting the need for further research on risks and consequences of nonmedical hallucinogen use.
Addictive behaviors
November 1, 2011
Jason A Ford, William C Watkins, Lindsey Blumenstein
19 citations
Using data from the 2009 National Survey on Drug Use and Health, which included nearly 70,000 respondents aged 12 and older across all 50 U.S. states and the District of Columbia, lifetime salvia use was reported by 1.66% of adolescents (ages 12–17) and 5.08% of adults (ages 18–34). Among adolescents, use correlated with age, gender, income, peer and parent attitudes toward substance use, and other drug use. Among adults, correlates included age, gender, race, religiosity, marital status, criminal involvement, and other substance use.
Addictive behaviors
June 1, 2026
Sebastian Ehmann, Nathan M Hager, Paul S Regier et al.
Using data from the 2023 U.S. National Survey on Drug Use and Health, lifetime use of mescaline or peyote was associated with lower opioid use disorder severity, while lifetime use of LSD, psilocybin, MDMA, or DMT was associated with higher severity. The link between mescaline/peyote use and lower severity appeared only among adults with high mental health impairment. The findings suggest that different types of psychedelic use have divergent relationships with opioid use disorder severity, and that mental health status may influence these associations.
Addictive behaviors
November 1, 2025
Samantha M Ross-Cypcar, Justin A Haegele, Jeanette M Garcia
Among disabled adults, past-year hallucinogen use is more common (8.37%) than among nondisabled adults (4.86%). Of disabled adults who used hallucinogens, nearly half reported a major depressive episode, over two-thirds reported serious psychological distress, and about 40% reported suicidal thinking, planning, or attempt. About 4% said hallucinogen use worsened or caused emotional or mental health problems. The findings come from a nationally representative sample of adults aged 18–50.